197 related articles for article (PubMed ID: 33289788)
21. Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
Shi KQ; Lin Z; Chen XJ; Song M; Wang YQ; Cai YJ; Yang NB; Zheng MH; Dong JZ; Zhang L; Chen YP
Oncotarget; 2015 Sep; 6(28):25093-108. PubMed ID: 26231037
[TBL] [Abstract][Full Text] [Related]
22. Integrative data mining and meta-analysis to investigate the prognostic role of microRNA-200 family in various human malignant neoplasms: A consideration on heterogeneity.
Yuan L; Bing Z; Yan P; Li R; Wang C; Sun X; Yang J; Shi X; Zhang Y; Yang K
Gene; 2019 Oct; 716():144025. PubMed ID: 31394177
[TBL] [Abstract][Full Text] [Related]
23. The Impact of MicroRNA-133a on Prognosis and Clinicopathological Parameters for Digestive System Cancers: a Comprehensive Study Based on Meta-Analysis and TCGA Database.
Zhu W; Ji X
Pathol Oncol Res; 2020 Apr; 26(2):771-781. PubMed ID: 30810894
[TBL] [Abstract][Full Text] [Related]
24. Aberrant expression of miR-196a in gastric cancers and correlation with recurrence.
Tsai KW; Liao YL; Wu CW; Hu LY; Li SC; Chan WC; Ho MR; Lai CH; Kao HW; Fang WL; Huang KH; Lin WC
Genes Chromosomes Cancer; 2012 Apr; 51(4):394-401. PubMed ID: 22420029
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-196a-5p is a potential prognostic marker of delayed lymph node metastasis in early-stage tongue squamous cell carcinoma.
Maruyama T; Nishihara K; Umikawa M; Arasaki A; Nakasone T; Nimura F; Matayoshi A; Takei K; Nakachi S; Kariya KI; Yoshimi N
Oncol Lett; 2018 Feb; 15(2):2349-2363. PubMed ID: 29434944
[TBL] [Abstract][Full Text] [Related]
26. Upregulation of hsa-miR-196a-5p is associated with MIR196A2 methylation and affects the malignant biological behaviors of glioma.
Qu S; Qiu O; Huang J; Liu J; Wang H
Genomics; 2021 May; 113(3):1001-1010. PubMed ID: 33636314
[TBL] [Abstract][Full Text] [Related]
27. Transforming growth factor-β1 promotes breast cancer metastasis by downregulating miR-196a-3p expression.
Chen Y; Huang S; Wu B; Fang J; Zhu M; Sun L; Zhang L; Zhang Y; Sun M; Guo L; Wang S
Oncotarget; 2017 Jul; 8(30):49110-49122. PubMed ID: 28418877
[TBL] [Abstract][Full Text] [Related]
28. miR-140 and miR-196a as Potential Biomarkers in Breast Cancer Patients.
Shahabi A; Naghili B; Ansarin K; Montazeri V; Zarghami N
Asian Pac J Cancer Prev; 2020 Jul; 21(7):1913-1918. PubMed ID: 32711415
[TBL] [Abstract][Full Text] [Related]
29. Prognostic role of microRNA-31 in various cancers: a meta-analysis.
Wang S; Hu J; Zhang D; Li J; Fei Q; Sun Y
Tumour Biol; 2014 Nov; 35(11):11639-45. PubMed ID: 25139099
[TBL] [Abstract][Full Text] [Related]
30. Has-MiR-196a-2 is up-regulated and acts as an independent unfavorable prognostic factor in thyroid carcinoma.
Fu YT; Zhang DQ; Zhou L; Li SJ; Sun H; Liu XL; Zheng HB
Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2707-2714. PubMed ID: 29771422
[TBL] [Abstract][Full Text] [Related]
31. Serum miR-10a-5p and miR-196a-5p as non-invasive biomarkers in non-small cell lung cancer.
Bao M; Pan S; Yang W; Chen S; Shan Y; Shi H
Int J Clin Exp Pathol; 2018; 11(2):773-780. PubMed ID: 31938164
[TBL] [Abstract][Full Text] [Related]
32. Serum miR-483-5p: a novel diagnostic and prognostic biomarker for patients with oral squamous cell carcinoma.
Xu H; Yang Y; Zhao H; Yang X; Luo Y; Ren Y; Liu W; Li N
Tumour Biol; 2016 Jan; 37(1):447-53. PubMed ID: 26224475
[TBL] [Abstract][Full Text] [Related]
33. Circulating microRNA-196a/b are novel biomarkers associated with metastatic gastric cancer.
Tsai MM; Wang CS; Tsai CY; Huang CG; Lee KF; Huang HW; Lin YH; Chi HC; Kuo LM; Lu PH; Lin KH
Eur J Cancer; 2016 Sep; 64():137-48. PubMed ID: 27420607
[TBL] [Abstract][Full Text] [Related]
34. Elevated expression level of microRNA-196a is predictive of intestinal-type intraductal papillary mucinous neoplasm of the pancreas.
Aso T; Ohtsuka T; Tamura K; Ideno N; Kono H; Nagayoshi Y; Ohuchida K; Ueda J; Takahata S; Shindo K; Aishima S; Oda Y; Mizumoto K; Tanaka M
Pancreas; 2014 Apr; 43(3):361-6. PubMed ID: 24622064
[TBL] [Abstract][Full Text] [Related]
35. Potential Targets and Clinical Value of MiR-224-5p in Cancers of the Digestive Tract.
Zhang L; Huang LS; Chen G; Feng ZB
Cell Physiol Biochem; 2017; 44(2):682-700. PubMed ID: 29169158
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of microRNA-145 in patients with various cancers: a meta-analysis.
Dai SL; Zhou J; Pan C; Huang G; Shi ZL; Yang SY; Yang KX
Cancer Biomark; 2015; 15(4):507-13. PubMed ID: 25792469
[TBL] [Abstract][Full Text] [Related]
37. Identification of microRNAs as novel biomarkers for esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas (TCGA) and bioinformatics.
Li CY; Zhang WW; Xiang JL; Wang XH; Li J; Wang JL
Chin Med J (Engl); 2019 Sep; 132(18):2213-2222. PubMed ID: 31490264
[TBL] [Abstract][Full Text] [Related]
38. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
[TBL] [Abstract][Full Text] [Related]
39. miR-196a-5p promotes metastasis of colorectal cancer via targeting IκBα.
Xin H; Wang C; Liu Z
BMC Cancer; 2019 Jan; 19(1):30. PubMed ID: 30621631
[TBL] [Abstract][Full Text] [Related]
40. Association of miR-193b down-regulation and miR-196a up-regulation with clinicopathological features and prognosis in gastric cancer.
Mu YP; Tang S; Sun WJ; Gao WM; Wang M; Su XL
Asian Pac J Cancer Prev; 2014; 15(20):8893-900. PubMed ID: 25374225
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
